IP Library › Patent Application 12464246
Patent Application
App. No. 12/464,246

ACE INHIBITOR-VASOPRESSIN ANTAGONIST COMBINATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/464,246
Abstract

Combinations of ACE inhibitors and vasopressin antagonists are useful to slow and reverse the process of ventricular dilation, and CHF in mammals.

Claims (4)

1 - 7 . (canceled)

8 . A method for treating ventricular dilation, and/or heart failure in a mammal comprising administering an effective amount of a combination of at least one angiotensin-converting enzyme inhibitor and conivaptan or a pharmaceutically acceptable salt thereof.

9 . A method for treating heart failure comprising administering to a patient suffering from New York Heart Association Class III or IV heart failure an effective amount of an angiotensin-converting enzyme inhibitor and, separately, an effective amount of conivaptan or a pharmaceutically acceptable salt thereof.

10 . The method according to claim 9 , wherein the method further comprises optionally administering an effective amount of a diuretic.